Empire Industries Ltd

Empire Industries Ltd

₹ 1,091 1.29%
10 Jun - close price
About

Incorporated in 1900, Empire Industries Ltd manufactures container glass, trades in frozen foods, and does indenting and property development[1]

Key Points

Services Offered:[1]
a) Manufacture of Amber Glass
Bottles for the Pharmaceutical
Industry.
b) Representing a number of foreign manufacturers of Precision Machine
Tools, Measuring Instruments, Testing Machines, designing and marketing of
Industrial Equipment.
c) Imports Frozen & Chilled Foods
from around the Globe and distribute
it to leading Hotels & Restaurants.
d) Provides office space on Leave
and License basis to multinational
companies and banks.
e) Developing residential, commercial
and industrial galas on the land measuring
35 Acres at Ambernath with NOC from MIDC.
f) Provides customizable co-sharing of office space solutions to clients to run their business without increasing start-up costs and overhead expenses.

  • Market Cap 654 Cr.
  • Current Price 1,091
  • High / Low 1,599 / 922
  • Stock P/E 19.0
  • Book Value 523
  • Dividend Yield 2.29 %
  • ROCE 14.4 %
  • ROE 11.2 %
  • Face Value 10.0

Pros

  • Company has been maintaining a healthy dividend payout of 42.1%
  • Company's working capital requirements have reduced from 78.8 days to 59.9 days

Cons

  • The company has delivered a poor sales growth of 3.33% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 12.1% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
192.06 147.88 184.10 171.99 177.62 147.64 153.53 152.85 152.01 151.67 163.41 175.50 186.39
166.80 131.63 164.58 156.02 150.73 131.93 134.76 145.89 129.31 135.30 144.12 157.58 170.32
Operating Profit 25.26 16.25 19.52 15.97 26.89 15.71 18.77 6.96 22.70 16.37 19.29 17.92 16.07
OPM % 13.15% 10.99% 10.60% 9.29% 15.14% 10.64% 12.23% 4.55% 14.93% 10.79% 11.80% 10.21% 8.62%
2.70 1.71 2.09 6.20 4.47 2.03 2.93 14.76 5.05 3.07 3.65 4.71 3.44
Interest 9.61 6.69 8.34 7.31 10.89 5.56 7.54 5.27 8.41 4.88 7.48 7.00 7.91
Depreciation 3.76 4.07 4.21 4.41 4.47 4.06 4.11 4.23 4.07 3.88 4.16 4.11 5.10
Profit before tax 14.59 7.20 9.06 10.45 16.00 8.12 10.05 12.22 15.27 10.68 11.30 11.52 6.50
Tax % 8.77% 17.36% 13.80% 21.53% 15.19% 24.63% 19.90% 16.37% 17.42% 9.36% 13.27% 8.68% 31.69%
13.30 5.95 7.81 8.20 13.57 6.12 8.06 10.22 12.60 9.69 9.81 10.52 4.44
EPS in Rs 22.17 9.92 13.02 13.67 22.62 10.20 13.43 17.03 21.00 16.15 16.35 17.53 7.40
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
248 352 385 405 473 526 575 490 544 682 606 677
251 290 324 338 411 467 500 447 485 603 542 607
Operating Profit -4 63 61 67 62 59 75 43 59 79 64 70
OPM % -2% 18% 16% 17% 13% 11% 13% 9% 11% 12% 11% 10%
70 5 5 6 27 33 12 23 10 14 25 15
Interest 11 9 10 14 16 20 32 35 27 33 27 27
Depreciation 8 12 10 9 13 11 15 19 15 17 16 17
Profit before tax 48 46 47 50 60 61 40 13 28 43 46 40
Tax % 24% 26% 34% 32% 22% 28% 15% -4% 14% 17% 19% 14%
36 34 31 34 47 44 34 13 24 36 37 34
EPS in Rs 60.42 56.90 51.08 56.78 77.78 73.07 56.97 22.02 39.48 59.20 61.67 57.42
Dividend Payout % 40% 42% 47% 44% 32% 34% 44% 114% 63% 42% 41% 44%
Compounded Sales Growth
10 Years: 7%
5 Years: 3%
3 Years: 8%
TTM: 12%
Compounded Profit Growth
10 Years: 0%
5 Years: 0%
3 Years: 14%
TTM: -6%
Stock Price CAGR
10 Years: -3%
5 Years: 16%
3 Years: 17%
1 Year: 8%
Return on Equity
10 Years: 13%
5 Years: 10%
3 Years: 12%
Last Year: 11%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 114 131 144 177 206 231 228 241 250 277 294 308
100 94 139 130 182 225 321 259 232 183 168 150
160 188 217 231 193 214 229 207 219 274 259 286
Total Liabilities 380 419 506 544 587 677 784 713 707 740 727 751
134 135 217 215 217 213 317 303 352 317 315 304
CWIP 70 84 0 0 57 103 72 75 9 9 0 0
Investments 0 0 0 0 0 0 0 0 0 1 29 11
175 199 289 329 313 361 395 335 346 412 383 435
Total Assets 380 419 506 544 587 677 784 713 707 740 727 751

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
8 40 34 48 20 -13 40 103 53 79 75 92
-42 -17 -3 -3 -49 -34 -45 -4 -2 29 -15 17
22 -23 13 -24 17 5 -5 -82 -45 -89 -52 -59
Net Cash Flow -12 -1 44 21 -12 -41 -11 17 6 19 7 50

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 89 61 74 68 71 80 70 64 83 104 98 76
Inventory Days 189 236 239 318 265 241 286 254 252 161 180 113
Days Payable 81 122 125 63 62 50 51 34 41 58 51 45
Cash Conversion Cycle 197 175 188 323 274 272 305 284 294 207 228 143
Working Capital Days 58 57 73 124 90 132 142 113 114 92 84 60
ROCE % 31% 24% 22% 21% 17% 14% 14% 9% 11% 16% 15% 14%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
72.55% 72.55% 72.55% 72.55% 72.55% 72.55% 72.55% 72.55% 72.55% 72.55% 72.55% 72.55%
12.10% 10.45% 8.93% 8.55% 7.48% 6.45% 6.38% 6.38% 6.37% 5.95% 5.95% 5.95%
15.35% 17.01% 18.50% 18.89% 19.95% 20.99% 21.06% 21.07% 21.07% 21.49% 21.50% 21.49%
No. of Shareholders 5,9706,6636,5616,5146,6226,7196,8336,9087,0447,5177,2877,309

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents